Department of Microbiology, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo 204-8588, Japan.
Med Mycol. 2023 Nov 6;61(11). doi: 10.1093/mmy/myad108.
Candida auris is an emerging fungal pathogen that is feared to spread of infection because of its propensity for multidrug resistance and high mortality rate. This pathogenic yeast is classified into four major clades by phylogenetic analyses, which are referred to the South Asia clade (clade I), East Asia clade (clade II), South Africa clade (clade III), and South America clade (clade IV), based on the location of the initial isolate. In this study, we evaluated the virulence of C. auris strains belonging to four major clades and the therapeutic effects of micafungin in a silkworm infection model. The highest mortality rate at 21 h after C. auris inoculation was observed for strains from clade IV (80% or more). In contrast, it was 20% or less in those from other clades. Antifungal susceptibility tests indicated resistance to fluconazole and sensitivity to echinocandins in the blood-derived strains. Micafungin prolonged the survival of blood-derived C. auris infected silkworms. These results suggest that the silkworm infection model is useful for evaluating the virulence of C. auris and determining its therapeutic effects.
耳念珠菌是一种新兴的真菌病原体,由于其具有多药耐药性和高死亡率的倾向,因此被担心会传播感染。这种致病性酵母菌通过系统发育分析被分为四个主要的分支,根据最初分离株的位置,分别被称为南亚分支(分支 I)、东亚分支(分支 II)、南非分支(分支 III)和南美洲分支(分支 IV)。在这项研究中,我们评估了属于四个主要分支的耳念珠菌菌株的毒力,以及在蚕感染模型中米卡芬净的治疗效果。在接种耳念珠菌后 21 小时,来自分支 IV 的菌株导致的死亡率最高(80%或更高)。相比之下,来自其他分支的菌株死亡率则为 20%或更低。抗真菌药敏试验表明,血液来源的菌株对氟康唑耐药,对棘白菌素类敏感。米卡芬净延长了血液来源的耳念珠菌感染蚕的存活时间。这些结果表明,蚕感染模型可用于评估耳念珠菌的毒力,并确定其治疗效果。